[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
作者信息
Sznajd J, Malczewska-Malec M, Idzior-Waluś B, Iwanejko J, Nowacki G
出版信息
Przegl Lek. 1987;44(12):837-43.
PMID:3330253
Abstract
摘要
相似文献
1
2
3
Effect of gemfibrozil on serum lipid levels.吉非贝齐对血脂水平的影响。
Artery. 1980;7(3):224-31.
4
Gemfibrozil--a new lipid lowering agent.吉非贝齐——一种新型降脂药。
J Med. 1980;11(2-3):107-16.
5
Clinical results with gemfibrozil and background to the Helsinki Heart Study.吉非贝齐的临床结果及赫尔辛基心脏研究背景。
Am J Cardiol. 1983 Aug 22;52(4):35B-38B. doi: 10.1016/0002-9149(83)90656-2.
6
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.正常、IIa型、III型和IV型高脂蛋白血症个体餐后脂蛋白代谢的不同模式。考来烯胺和吉非贝齐治疗的效果。
J Clin Invest. 1987 Apr;79(4):1110-9. doi: 10.1172/JCI112926.
7
[Gemfibrozil in the treatment of hyperlipoproteinemias].
Vutr Boles. 1991;30(2):56-8.
8
Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.吉非贝齐加考来烯胺治疗家族性高胆固醇血症
Lancet. 1988 Apr 2;1(8588):776. doi: 10.1016/s0140-6736(88)91591-7.
9
Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.吉非贝齐治疗难治性家族性高胆固醇血症和Ⅲ型高脂蛋白血症。
J R Soc Med. 1988 May;81(5):274-6. doi: 10.1177/014107688808100512.
10
Combination drug therapy for familial combined hyperlipidemia.家族性混合性高脂血症的联合药物治疗。
Ann Intern Med. 1988 Jul 1;109(1):25-32. doi: 10.7326/0003-4819-109-1-25.
Zotero 插件